antiretroviral drugs tuberculosis control era hiv/aids 
human immunodeficiency virus/acquired immunodeficiency syndrome hiv/ aids dramatically increased incidence tuberculosis tb sub-saharan africa % tb patients coinfected hiv year tb deaths attributable hiv coinfection now hiv threatens control tb asia eastern europe latin america antiretroviral arv drugs can prevent tb preserving immunity cohort analysis shows early therapy plus high levels coverage compliance will needed avert significant fraction tb cases however arv drugs enhance treatment tb tb programs provide important entry point treatment hiv/ aids 
